Perfil
Yang Sheng Lin is currently General Manager, Director & Chief Researcher at Tripartite Therapeutics, Inc. since 2015.
Formerly, Dr. Lin was Chief Scientific Officer at Medigen Biotechnology Corp.
from 2012 to 2014.
Education includes a doctorate from Harvard University.
Cargos activos de Yang Sheng Lin
| Empresas | Cargo | Inicio |
|---|---|---|
| TRIPARTITE THERAPEUTICS INC. | Director/Miembro de la Junta | 01/08/2015 |
Antiguos cargos conocidos de Yang Sheng Lin.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDIGEN BIOTECHNOLOGY CORP. | Director Técnico/Científico/I+D | - |
Formación de Yang Sheng Lin.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medigen Biotechnology Corp.
Medigen Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops and produces biopharmaceutical products | Health Technology |
Hanyang Biotechnology Ltd.
Hanyang Biotechnology Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs and antibody-drug conjugate therapies for cancer | Health Technology |
- Bolsa de valores
- Insiders
- Yang Sheng Lin
















